$CODX Abbott is on their knees with antigen tests publicly right now...anybody who can read, or with the IQ of a tulip, knows they are catastrophically inaccurate on asymptomatic people. But, they are not sitting on their hands. They have just licensed a new, non molecular technology that can multiplex in a broad array of testing, which looks like it could include liquid biopsy. Dwight, you need to move fast, they are coming after what should be your market share...hands down. Go pick the tomatoes ๐Ÿ…. 360dx.com/immunoassays/quan...
  • 10
10 Likes